Exact Mass: 341.29297840000004

Exact Mass Matches: 341.29297840000004

Found 33 metabolites which its exact mass value is equals to given mass value 341.29297840000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Stearoylglycine

N-(Carboxymethyl)octadecanamide

C20H39NO3 (341.29297840000004)


Stearoylglycine is an acylglycine with C-18 fatty acid group as the acyl moiety. Acylglycines 1 possess a common amidoacetic acid moiety and are normally minor metabolites of fatty acids. Elevated levels of certain acylglycines appear in the urine and blood of patients with various fatty acid oxidation disorders. They are normally produced through the action of glycine N-acyltransferase which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine ↔ CoA + N-acylglycine. Stearoylglycine is an acylglycine with C-18 fatty acid group as the acyl moiety.

   

N-Palmitoyl GABA

4-[(1-hydroxyhexadecylidene)amino]butanoic acid

C20H39NO3 (341.29297840000004)


N-Palmitoyl GABA is also known as 4-hexadecanoylamino-Butyric acid. N-Palmitoyl GABA is considered to be practically insoluble (in water) and acidic. N-Palmitoyl GABA is a fatty amide lipid molecule

   

N-Myristoyl Isoleucine

3-methyl-2-tetradecanamidopentanoic acid

C20H39NO3 (341.29297840000004)


N-myristoyl isoleucine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Isoleucine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Isoleucine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Isoleucine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Myristoyl Leucine

4-methyl-2-tetradecanamidopentanoic acid

C20H39NO3 (341.29297840000004)


N-myristoyl leucine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Leucine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Leucine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Leucine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-(1,3-Dihydroxyoctadec-4-en-2-yl)acetamide

N-(1,3-Dihydroxyoctadec-4-en-2-yl)acetamide

C20H39NO3 (341.29297840000004)


   
   

C2 Ceramide

N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-acetamide

C20H39NO3 (341.29297840000004)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors A N-acylsphingosine that has an acetamido group at position 2. D004791 - Enzyme Inhibitors C2 Ceramide (Ceramide 2) is the main lipid of the stratum corneum and a protein phosphatase 1 (PP1) activator. C2 Ceramide activates PP2A and ceramide-activated protein phosphatase (CAPP). C2 Ceramide induces cells differentiation, autophagy and apoptosis, inhibits mitochondrial respiratory chain complex III. C2 Ceramide is also a skin conditioning agent that protects the epidermal barrier from water loss[1][2][3][4][5].

   

EMA-1

N-octadecanoyl-glycine

C20H39NO3 (341.29297840000004)


   

N-palmitoyl GABA

N-hexadecanoyl-gamma-aminobutyric acid

C20H39NO3 (341.29297840000004)


   

NA 20:1;O2

N-hexadecanoyl-gamma-aminobutyric acid

C20H39NO3 (341.29297840000004)


   
   

(R)-12-hydroxy-N-(2-hydroxyethyl)oleamide

(R)-12-hydroxy-N-(2-hydroxyethyl)oleamide

C20H39NO3 (341.29297840000004)


   

N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide

N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide

C20H39NO3 (341.29297840000004)


   

N-(1,3-Dihydroxyoctadec-4-en-2-yl)acetamide

N-(1,3-Dihydroxyoctadec-4-en-2-yl)acetamide

C20H39NO3 (341.29297840000004)


   

N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]butanamide

N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]butanamide

C20H39NO3 (341.29297840000004)


   

N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]pentanamide

N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]pentanamide

C20H39NO3 (341.29297840000004)


   

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]heptanamide

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]heptanamide

C20H39NO3 (341.29297840000004)


   

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]nonanamide

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]nonanamide

C20H39NO3 (341.29297840000004)


   

N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]propanamide

N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]propanamide

C20H39NO3 (341.29297840000004)


   

N-[(E)-1,3-dihydroxynon-4-en-2-yl]undecanamide

N-[(E)-1,3-dihydroxynon-4-en-2-yl]undecanamide

C20H39NO3 (341.29297840000004)


   

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]octanamide

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]octanamide

C20H39NO3 (341.29297840000004)


   

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]dodecanamide

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]dodecanamide

C20H39NO3 (341.29297840000004)


   

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]hexanamide

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]hexanamide

C20H39NO3 (341.29297840000004)


   

N-[(E)-1,3-dihydroxydec-4-en-2-yl]decanamide

N-[(E)-1,3-dihydroxydec-4-en-2-yl]decanamide

C20H39NO3 (341.29297840000004)


   

N-octadecanoylglycine

N-octadecanoylglycine

C20H39NO3 (341.29297840000004)


A fatty acid amide resulting from the formal condensation of the carboxy group of octadecanoic acid with the amino group of glycine.

   
   

14-[5-hydroxy-6-(hydroxymethyl)piperidin-2-yl]tetradecan-2-one

14-[5-hydroxy-6-(hydroxymethyl)piperidin-2-yl]tetradecan-2-one

C20H39NO3 (341.29297840000004)